AChE/BuChE-IN-3

Modify Date: 2024-04-10 17:48:38

AChE/BuChE-IN-3 Structure
AChE/BuChE-IN-3 structure
Common Name AChE/BuChE-IN-3
CAS Number 2742707-47-5 Molecular Weight 585.57
Density N/A Boiling Point N/A
Molecular Formula C30H30F3N3O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of AChE/BuChE-IN-3


AChE/BuChE-IN-3 (compound C4) is a potent and blood-brain barrier (BBB) penetrant AChE and BuChE dual inhibitor with IC50s of 0.65 μM and 5.77 μM for AChE and BuChE. AChE/BuChE-IN-3 also inhibits Aβ1-42 aggregation. AChE/BuChE-IN-3 has effectively neuroprotective activities and nearly no toxicity on SH-SY5Y cells. AChE/BuChE-IN-3 can be used for researching Alzheimer's disease[1].

 Names

Name AChE/BuChE-IN-3

 AChE/BuChE-IN-3 Biological Activity

Description AChE/BuChE-IN-3 (compound C4) is a potent and blood-brain barrier (BBB) penetrant AChE and BuChE dual inhibitor with IC50s of 0.65 μM and 5.77 μM for AChE and BuChE. AChE/BuChE-IN-3 also inhibits Aβ1-42 aggregation. AChE/BuChE-IN-3 has effectively neuroprotective activities and nearly no toxicity on SH-SY5Y cells. AChE/BuChE-IN-3 can be used for researching Alzheimer's disease[1].
Related Catalog
Target

IC50: 5.77 μM (BuChE), 0.65 μM (AChE)[1]

In Vitro AChE/BuChE-IN-3 (compound C4) (12.5-100 μM; 48 hours) exhibits no cytotoxicity on the human neuroblastoma cell line SH-SY5Y, and slightly increases cell viabilities[1]. Cell Viability Assay Cell Line: SH-SY5Y[1] Concentration: 12.5 μM, 25 μM, 50 μM and 100 μM Incubation Time: 48 hours Result: Exhibited no cytotoxicity on the human neuroblastoma cell line SH-SY5Y, and slightly increased cell viabilities.
References

[1]. Shi S, et al. Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease. Bioorg Chem. 2020 Jul;100:103917.

 Chemical & Physical Properties

Molecular Formula C30H30F3N3O6
Molecular Weight 585.57
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.